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INTRODUCTION
During the last few decades, huge advance has been 
made in human genetics in point of detecting the loci 
of human traits and diseases and linkage analysis is 
one of the techniques that contributed the most to this 
advance.
Linkage analysis is based on Mendel’s second 
law, the law of independent random assortment 
which deals with the joint behavior of alleles at two 
loci. When two genetic loci, the marker locus and the 
trait locus, lie proximally on the same chromosome, 
they tend to cosegregate within families. The loci are 
linked. The first to realize this was Morgan TH1 with 
his experiments on Drosophila melanogaster while 
the first genetic linkage in man was made by Bell J 
and Haldane JB when they noted the linkage between 
haemophilia and colour-blindness2. Meanwhile, Mor-
ton NE proposed as a statistic to assess possible link-
age the logarithm of an odds ratio score (LOD score)3. 
The odds ratio is the odds of occurrence of observed 
genotypes in the framework of the proposed model 
under the assumption of linkage to the odds computed 
on independent assortment. Thus, high LOD scores 
favor the linkage hypothesis and score close to 1 favor 
independent assortment. In particular, a LOD score of 
3 is considered to be a statistical significant evidence 
for linkage, while a score of -2 is evidence against it4,5. 
Linkage studies were primarily used for diseases 
showing Mendelian inheritance which were caused by 
highly penetrant alleles and there are numerous suc-
cessful examples of it. On the other hand, the first re-
sults after using the same technique for complex traits 
and diseases were not statistically significant with 
linkage being hard to find6. This article presents the 
basic principles and steps that could be followed to 
approach a disease with the use of linkage analysis. 
Many examples are described, but in the same time 
some problems that are found frequently are also pre-
sented.
The starting point
Linkage analysis studies begin with a set of families 
in which the disease segregates. The diagnosis of the 
phenotype should be unambiguous. The pedigrees are 
drawn and a pattern of inheritance is estimated. Large 
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families with multiple cases have a greater power on 
revealing a clear pattern of inheritance and detecting 
the disease locus than multiple small families, and 
thus they should be preferred7.
Simple Mendelian diseases such as cystic fibro-
sis8,9, Huntington disease10 and polycystic kidney dis-
ease11, with a least ambiguous diagnosis and a one-to-
one correspondence between phenotype and genotype 
were the first to be successfully studied. When the 
diagnosis is not certain and there is disease heteroge-
neity or complex and unclear inheritance we must be 
far more precautious or else linkage studies will fail12.
Approach by the use of linkage analysis
The selected families, including those of their mem-
bers who do have the phenotype and those who do 
not, are analyzed for linkage using a group of mark-
ers. The first markers that were used were the various 
blood group loci. Anderson DE linked the naveoid 
basal cell carcinoma syndrome (NBCCS) with Rhe-
sus locus13 and Bird TD et al linked Charcot-Marie-
Tooth with the Duffy locus14, both on chromosome 1, 
while Harper PS et al linked myotonic dystrophy with 
the Lutheran blood group locus15. But the real revolu-
tion came with the proposal of genome-wide linkage 
analysis using anonymous DNA polymorphisms16. 
Restriction fragment length polymorphisms (RFLPs), 
simple sequence repeats and today simple nucleotide 
polymorphisms (SNPs) and microsatellite DNA are 
all used as markers, providing us with some useful 
results17,18,19.
An initial set of markers spaced about 5-10 cM 
apart is used in order to detect an area of high link-
age interest12. Naylor SL et al examined 14 families 
with cystic fibrosis for linkage with three markers. His 
results revealed significance linkage and indeed his 
analysis indicated a specific order; COL-pJ3.11-CF-
MET20. Moreover, Lebo RV et al using a small set of 
markers detected the gene of CMT disease in an area 
of 18 cM between the genes of Duffy blood group and 
antithrombine III (AT3)21.
Linkage studies have been reinforced by the 
construction of genetic maps of the human chromo-
somes, an idea which was proposed by Botstein D et 
al16. Soon after Botstein’s idea, maps of the different 
chromosome were presented22,23,24, maps which were 
continuously enriched by newer and more in number 
polymorphisms. This kind of map used Lebo RV et 
al in his research21,23. A genetic map of the whole hu-
man genome was constructed by Green P et al using 
RFLPs25. Modern maps using as polymorphisms the 
huge number of SNPs and microsatellite DNA are the 
first part of the genetic approach of both complex and 
mendelian diseases.
After detecting an initial linkage within a region, 
the standard procedure is to re-examine the same 
pedigrees with markers placed more closely in that 
area of interest12. This is what Michon L et al did in 
their work over congenital microphthalmia26. Morle L 
et al had detected the responsible gene in a 13.8 cM 
region on chromosome 15q12-q1527. Michon L et al 
re-examined this region with new microsatellite DNA 
markers and managed to restrict it into two smaller 
regions with size 1.9 and 2.5 Mb respectively, regions 
which are very closely spaced on chromosome 1526. In 
more favorable cases this procedure results in a small 
number of genes in the region that might be relevant 
with the disease, otherwise there can be more than a 
hundred of them as candidates.
Heterogeneity
A common problem that linkage studies had to cope 
with from the early beginning was locus and disease 
heterogeneity7. Locus heterogeneity refers to a situa-
tion where the same disease can be caused by multiple 
loci independently. This particularly means that when 
the sample of the study is consisted of a large set of 
families, it is likely that all families are not linked to 
the same locus. Disease heterogeneity exists in dis-
eases that have subtypes, grades or stages. A standard 
approach for dealing with heterogeneity is by split-
ting the large sample of families into multiple smaller 
ones7. Families in which the disease has common pat-
tern of inheritance or common clinical symptoms and 
laboratory findings, and as a result the disease in them 
may be of the same subtype, can be presented as a new 
sample and can be analyzed separately.
A very useful example for understanding heteroge-
neity is that of Charcot-Marie-Tooth disease (CMT). 
CMT is an extremely heterogeneous disease, as it ap-
pears with a great variety of clinical symptoms and 
inheritance patterns28. Therefore it has heterogene-
ity - clinical, genetic and hereditary. Initial studies 
showed linkage with the Duffy blood group locus 
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on chromosome 114. On the other hand, other studies 
failed to confirm such linkage. Finally two research 
groups, Dyck PJ et al and Bird TD et al, proposed the 
hypothesis of heterogeneity. They named the fami-
lies which showed linkage to Duffy locus as type B 
and those which did not show linkage as type A and 
studied them separately29,30. This was the first step that 
led to the detection of the responsible genes and their 
proteins, myelin protein zero (MPZ) and peripheral 
myelin protein 22 (PMP22) respectively31,32.
Candidate genes
Candidate gene is a gene which is localized in the 
relevant region that linkage studies have already rec-
ognized and its protein product seems to be related 
to the disease12. As mentioned above, this region may 
include a number of genes that may vary from less 
than ten to more than some hundreds. Linkage analy-
sis is able to identify the region, but in order to con-
sider a gene as a probable candidate more informa-
tion is required. Physiological and pathophysiological 
knowledge, previous genetic studies and animal mod-
els, they all should be taken into account33. Genome 
Database and Online Mendelian Inheritance in Man 
(OMIM) are useful tools for today’s researchers as 
they can provide them easily and rapidly, with a list 
including all the genes in the relevant region12,34.
At this point, linkage analysis becomes insuffi-
cient by itself and genetic studies need help from other 
techniques. Sequencing is the technique used next35,36. 
Sequencing the candidate gene can accentuate the re-
sponsible for the disease mutation. However this is 
not the end of the research. The most important thing 
is to reassure that what has been found is not anoth-
er new polymorphism. Cosegregation of the mutant 
allele with the disease, absence in controls and low 
frequency in general population are the criteria which 
must be fulfilled37. Finally, functional, tissue expres-
sion and animal model studies offer the crucial addi-
tional support for the definite connection between a 
single gene or a single mutation and a specific disease 
or phenotype in general12. Following all these steps 
and based on previous work, Miki Y et al identified 
BRCA1 in the centre of the suspected 600-kb region 
of 17q21 between markers D17S1321 and D17S1325 
showing that the essential criteria are fulfilled37. Be-
fore that, but using similar methodology, Hayasaka 
K et al identified MPZ as the responsible gene for 
CMT1B38 and afterwards Boerkoel CF et al linked 
periaxin mutations with Dejerine-Sottas neuropathy39.
However all the candidate genes studies do not 
reach the desirable success. In fact, many unsuccess-
ful studies have anteceded a single one successful. 
The first candidate gene for CMT1B was the gene 
of Fc-gamma receptors which in the end was not af-
firmed21. In the same way Michon L et al excluded 
three candidate genes for congenital microphthalmia 
(CKTSF1B1, CX36 and KLF13) as they found no 
mutations in these genes after PCR-amplification and 
sequencing in affected subjects and healthy controls26.
DISCUSSION
As Botstein D and Risch N wrote, “connecting phe-
notype with genotype is the fundamental aim of ge-
netics”12. During the last decades, many steps have 
been made towards this direction and linkage analy-
sis, since the experiments of Morgan TH1 and Bell 
J2, has been a pioneer. Despite the fact that Risch N 
and Merikangas K declared linkage studies’ death in 
199640, they continue to be used till today to prioritize 
other genetic techniques.
The availability of computer software to process 
the huge amount of data from linkage studies as well 
as the nomination of new DNA polymorphisms which 
made linkage studies cheaper and faster were the 
cause of the scientific explosion at the 1980s and af-
terwards that lead to the connection of hundreds of 
genes with diseases. The main polymorphisms used 
today are microsatellite DNA and SNPs. They are both 
highly polymorphic and equally dispread through the 
genome. There is a strong argument concerning the 
suitability of the markers used for each study41,42,43,44. 
Microsattelite markers are considered to be more in-
formative than SNPs, although SNPs are more abun-
dant. Furthermore, a larger number of SNPs is needed 
to achieve information content similar to that of mi-
crosatellite DNA, but on the other hand, SNPs result 
in higher LOD scores and narrower linkage region. 
In conclusion, the currency of new software for the 
statistical process of the linkage studies’ data and in-
dustrial arrays with a large number of SNPs will boost 
their use.
Firstly, the main interest concerned the mendelian 
diseases. They show a simple pattern of inheritance 
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and in most cases they are caused by rare, highly pen-
etrant alleles. Nowadays, genetic studies have turned 
their interest on complex diseases and complex traits. 
This interest is pleaded because of their great preva-
lence and great effect on total human morbidity and 
mortality. Detecting complex traits is a real challenge 
for geneticists as complex diseases are the result of 
many genes acting together, each one of which has 
a small effect on the final phenotype and moreover, 
they receive major environmental impact which is 
not completely understood yet45. Genetic studies on 
complex diseases aim to clear the darkness that exists 
on the way environmental and genomic factors affect 
each other and result to the final phenotype. This can 
increase our knowledge over complex diseases and 
can reveal new therapeutic targets. Criswell LA et al 
with their analysis over rheumatoid arthritis showed 
the potential importance of sex and other quantitative 
components of the disease on genetic factors that may 
finally influence the risk of specific manifestations,46 
while Zhang Y et al found linkage between variants 
on chromosome 13q14 and atopy and severe clinical 
asthma47 and Johnson L et al’s meta-analysis showed 
linkage evidence between BMI and chromosome 8p48.
From the above, it is easily comprehensible that 
linkage analysis, despite being old, is not superannu-
ated at all. It still plays a key role in modern genetic 
panorama. The late advances in Bioinformatics which 
have made genome-wide scans a reality and the re-
sults of the combination with techniques such as map-
ping studies, association studies (GWAS) and new 
generation sequencing, show that linkage analysis is 
a powerful tool in the geneticists’ quiver.
ΠΕΡΙΛΗΨΗ: Η ανάλυση σύνδεσης, η οποία βασίζεται στον νόμο της ανεξάρτητης κληρονόμησης του Μέντελ, έχει συνεισφέ-
ρει τα μέγιστα στην πρόσφατη πρόοδο της γενετικής. Στο παρόν άρθρο παρουσιάζεται ο τρόπος προσέγγισης μιας ασθένειας 
με την χρήση αυτής της μεθόδου. Το πρώτο βήμα συνίσταται στη σωστή επιλογή μιας ομάδας από οικογένειες στις οποίες η 
ασθένεια κληρονομείται. Προτιμούνται τα μεγάλα γενεαλογικά δένδρα. Στη συνέχεια όλα τα μέλη αυτών των οικογενειών 
αναλύονται με τη χρήση μιας αρχικής ομάδας από δείκτες με σκοπό την ανίχνευση περιοχής υψηλού ενδιαφέροντος. Μια 
κοινή προσέγγιση αποτελεί η επανεξέταση των ίδιων οικογενειών με δείκτες που βρίσκονται πιο κοντά μεταξύ τους στο 
χρωμόσωμα έτσι ώστε να περιοριστεί η σχετική περιοχή. Έπειτα, λαμβάνοντας υπόψη την υπάρχουσα γνώση, καταστρώνε-
ται η υπόθεση του υποψήφιου γονιδίου και γίνεται προσπάθεια απόδειξής της. Η τελική μελέτη, όπως επίσης και το τελικό 
αποτέλεσμα, επηρεάζονται και τα δύο από το είδος των οικογενειών που θα επιλεχθούν, την καταλληλότητα των δεικτών και 
τα κριτήρια που θα χρησιμοποιηθούν για την απόδειξη της υπόθεσης του υποψήφιου γονιδίου. Οι μεντελικές ασθένειες ήταν 
οι πρώτες που μελετήθηκαν, ωστόσο η πραγματική πρόκληση για τους γενετιστές είναι η ανακάλυψη γενετικών θέσεων που 
επηρεάζουν τις σύνθετες ασθένειες και η ανάλυση σύνδεσης παραμένει ακόμα μια αποτελεσματική προσέγγιση.
Λέξεις Κλειδιά: Ανάλυση σύνδεσης, Μενδελικές ασθένειες, Ετερογένεια, Υποψήφιο γονίδιο.
Μια προσέγγιση νόσου χρησιμοποιώντας την ανάλυση σύνδεσης:  
Παραμένει ακόμα στη φαρέτρα των γενετιστών.
Αναστάσιος Ν. Τζαβέλλας, Αλέξανδρος Φ. Λαμπρόπουλος
Εργαστήριο Γενικής Βιολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης
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